These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2068977)

  • 1. Hapten carrier conjugates associated with halothane hepatitis.
    Pohl LR; Thomassen D; Pumford NR; Butler LE; Satoh H; Ferrans VJ; Perrone A; Martin BM; Martin JL
    Adv Exp Med Biol; 1991; 283():111-20. PubMed ID: 2068977
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug hypersensitivity and the etiology of toxic hepatitis].
    Nagashima H; Koide N
    Nihon Rinsho; 1985 Jun; 43(6):1121-6. PubMed ID: 3900463
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for antibodies associated with halothane hepatitis.
    Hastings KL; Thomas C; Hubbard AK; Gandolfi AJ
    Br J Anaesth; 1991 Dec; 67(6):722-8. PubMed ID: 1768541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of structural alterations in the synthesis of halothane metabolite antigens to mimic halothane-induced immunogen.
    Hubbard AK; Levy JP; Roth TP; Gandolfi AJ
    Drug Chem Toxicol; 1990; 13(2-3):93-112. PubMed ID: 1703476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of cellular hypersensitivity in patients with unexplained hepatitis following halothane.
    Walton B; Hamblin A; Dumonde DC; Simpson R
    Anesthesiology; 1976 May; 44(5):391-7. PubMed ID: 1267204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halothane hepatitis: a model of immune mediated drug hepatotoxicity.
    Neuberger J; Kenna JG
    Clin Sci (Lond); 1987 Mar; 72(3):263-70. PubMed ID: 3545644
    [No Abstract]   [Full Text] [Related]  

  • 7. Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase.
    Martin JL; Kenna JG; Martin BM; Thomassen D; Reed GF; Pohl LR
    Hepatology; 1993 Oct; 18(4):858-63. PubMed ID: 8406360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-ethylthiotrifluoroacetate enhancement of the immune response to halothane in the guinea pig.
    Hastings KL; Schuman S; Brown AP; Thomas C; Gandolfi AJ
    Adv Exp Med Biol; 1991; 283():739-44. PubMed ID: 2069050
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular basis of halothane hepatitis.
    Gut J
    Arch Toxicol Suppl; 1998; 20():3-17. PubMed ID: 9442277
    [No Abstract]   [Full Text] [Related]  

  • 10. Halothane hepatitis: allergy or idiosyncrasy?
    Dienstag JL
    N Engl J Med; 1980 Jul; 303(2):102-4. PubMed ID: 7383060
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure to induce hepatic pathology in animals sensitized to a halothane metabolite and subsequently challenged with halothane.
    Reves JG; McCracken LE
    Anesth Analg; 1976; 55(2):235-42. PubMed ID: 943984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halothane hepatitis. Current concepts.
    Reves JG
    Postgrad Med; 1974 Oct; 56(4):65-70. PubMed ID: 4213134
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity to halothane metabolite-modified proteins in halothane hepatitis.
    Kenna JG; Knight TL; van Pelt FN
    Ann N Y Acad Sci; 1993 Jun; 685():646-61. PubMed ID: 8363272
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of hypersensitivity to a halothane metabolite on halothane-induced liver damage.
    Ford DJ; Coyle DE; Harrington JF
    Anesthesiology; 1984 Feb; 60(2):141-3. PubMed ID: 6696235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of conjugates of a catabolite common to halothane, enflurane and fluroxene in guinea pigs].
    Mathieu A; Di Padua D
    Ann Anesthesiol Fr; 1976; 17(3):311-4. PubMed ID: 10782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.
    Kenna JG; Satoh H; Christ DD; Pohl LR
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1103-9. PubMed ID: 3385639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Halothane immunity and hepatitis].
    Aji T; Shiaku Y; Kosaka N
    Masui; 1975 May; 24(5):421-9. PubMed ID: 1172015
    [No Abstract]   [Full Text] [Related]  

  • 18. Halothane in Britain today.
    Strunin L; Simpson BR
    Br J Anaesth; 1972 Sep; 44(9):919-24. PubMed ID: 4564264
    [No Abstract]   [Full Text] [Related]  

  • 19. Halothane hepatitis and the anaesthesiologist.
    Shipton EA; Kruger AE
    S Afr Med J; 1984 Jan; 65(3):86-9. PubMed ID: 6364393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic pathology and skin test reactions to trifluoro-acetylated autologous protein after repeated halothane anaesthesia in the guineapig.
    Reves JG; McCracken LE
    Br J Anaesth; 1976 May; 48(5):419-24. PubMed ID: 1276014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.